Drug profile · INN
ceritinib
ZYKADIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ceritinib (ZYKADIA) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN ceritinib
Brand ZYKADIA
Route ORAL
Formulation CAPSULE
ATC code L01XE
Originator Novartis Pharmaceuticals
Frequently asked questions
What is ceritinib?
ceritinib (ZYKADIA) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ceritinib?
ZYKADIA is a marketed brand name for ceritinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ceritinib?
ceritinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.